Articles citing this paper
Natural Product-Inspired Pyranonaphthoquinone Inhibitors of Indoleamine 2,3-Dioxygenase-1 (IDO-1)*
David J. A. Bridewell A , Jonathan Sperry B , Jason R. Smith C , Priambudi Kosim-Satyaputra C , Lai-Ming Ching A , Joanne F. Jamie C and Margaret A. Brimble B D
+ Author Affiliations
- Author Affiliations
A Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland Central 1010, New Zealand.
B School of Chemical Sciences, The University of Auckland, Auckland Central 1010, New Zealand.
C Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW 2109, Australia.
D Corresponding author. Email: m.brimble@auckland.ac.nz
Australian Journal of Chemistry 66(1) 40-49 https://doi.org/10.1071/CH12393
Submitted: 23 August 2012 Accepted: 29 October 2012 Published: 12 November 2012
20 articles found in Crossref database.
Pyranonaphthoquinones – isolation, biology and synthesis: an update
Naysmith Briar J.,
Hume Paul A.,
Sperry Jonathan, Brimble Margaret A.
Natural Product Reports. 2017 34(1). p.25
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1)
Fung Sai-Parng S.,
Wang Haiyan,
Tomek Petr,
Squire Christopher J.,
Flanagan Jack U.,
Palmer Brian D.,
Bridewell David J.A.,
Tijono Sofian M.,
Jamie Joanne F., Ching Lai-Ming
Bioorganic & Medicinal Chemistry. 2013 21(24). p.7595
Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy
Weng Tianwei,
Qiu Xiaqiu,
Wang Jubo,
Li Zhiyu, Bian Jinlei
European Journal of Medicinal Chemistry. 2018 143 p.656
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy
Lin Shu-Yu,
Yeh Teng-Kuang,
Kuo Ching-Chuan,
Song Jen-Shin,
Cheng Ming-Fu,
Liao Fang-Yu,
Chao Min-Wu,
Huang Han-Li,
Chen Yi-Lin,
Yang Chun-Yu,
Wu Mine-Hsine,
Hsieh Chia-Ling,
Hsiao Wenchi,
Peng Yi-Hui,
Wu Jian-Sung,
Lin Li-Mei,
Sun Manwu,
Chao Yu-Sheng,
Shih Chuan,
Wu Su-Ying,
Pan Shiow-Lin,
Hung Ming-Shiu, Ueng Shau-Hua
Journal of Medicinal Chemistry. 2016 59(1). p.419
IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery
Qian Shan,
Zhang Man,
Chen Quanlong,
He Yanying,
Wang Wei, Wang Zhouyu
RSC Advances. 2016 6(9). p.7575
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
Röhrig Ute F.,
Reynaud Aline,
Majjigapu Somi Reddy,
Vogel Pierre,
Pojer Florence, Zoete Vincent
Journal of Medicinal Chemistry. 2019 62(19). p.8784
Effects of Various Phytochemicals on Indoleamine 2,3-Dioxygenase 1 Activity: Galanal Is a Novel, Competitive Inhibitor of the Enzyme
Yamamoto Rie,
Yamamoto Yasuko,
Imai Shinjiro,
Fukutomi Ryuta,
Ozawa Yoshio,
Abe Masako,
Matuo Yushi,
Saito Kuniaki, Ikeda Kazutaka
PLoS ONE. 2014 9(2). p.e88789
Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Röhrig Ute F.,
Majjigapu Somi Reddy,
Vogel Pierre,
Zoete Vincent, Michielin Olivier
Journal of Medicinal Chemistry. 2015 58(24). p.9421
Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3
Huang Rizhen,
Jing Xiaoteng,
Huang Xiaochao,
Pan Yingming,
Fang Yilin,
Liang Guibin,
Liao Zhixin,
Wang Hengshan,
Chen Zhenfeng, Zhang Ye
Journal of Medicinal Chemistry. 2020 63(4). p.1544
Heme-containing enzymes and inhibitors for tryptophan metabolism
Yan Daojing,
Lin Ying-Wu, Tan Xiangshi
Metallomics. 2017 9(9). p.1230
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Wang Xiu-Xiu,
Sun Si-Yu,
Dong Qing-Qing,
Wu Xiao-Xiang,
Tang Wei, Xing Ya-Qun
MedChemComm. 2019 10(10). p.1740
Synthesis of the Griseusin B Framework via a One-Pot Annulation–Methylation–Double Deprotection–Spirocyclization Sequence
Naysmith Briar J., Brimble Margaret A.
Organic Letters. 2013 15(8). p.2006
Research progress of indoleamine 2,3-dioxygenase inhibitors
Jiang Tianze,
Sun Yingying,
Yin Zhichao,
Feng Sen,
Sun Liping, Li Zhiyu
Future Medicinal Chemistry. 2015 7(2). p.185
Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2
Tijono Sofian M,
Palmer Brian D.,
Tomek Petr,
Flanagan Jack U.,
Henare Kimiora,
Gamage Swarna,
Braun Lukas, Ching Lai-Ming
Pharmaceuticals. 2022 15(9). p.1090
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Röhrig Ute F.,
Majjigapu Somi Reddy,
Chambon Marc,
Bron Sylvian,
Pilotte Luc,
Colau Didier,
Van den Eynde Benoît J.,
Turcatti Gerardo,
Vogel Pierre,
Zoete Vincent, Michielin Olivier
European Journal of Medicinal Chemistry. 2014 84 p.284
Design, synthesis and biological evaluation of novel aryl-acrylic derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors
Hu Hao,
Li Ming,
Wu Di,
Li Zhiwei,
Miao Ruifeng,
Liu Yajing, Gong Ping
Bioorganic & Medicinal Chemistry. 2019 27(14). p.3135
Formal synthesis of nanaomycin D via a Hauser–Kraus annulation using a chiral enone-lactone
Hassan Najmah P.S.,
Naysmith Briar J.,
Sperry Jonathan, Brimble Margaret A.
Tetrahedron. 2015 71(39). p.7137
Computer‐aided drug design in new druggable targets for the next generation of immune‐oncology therapies
Acúrcio Rita C.,
Scomparin Anna,
Satchi‐Fainaro Ronit,
Florindo Helena F., Guedes Rita C.
WIREs Computational Molecular Science. 2019 9(3).
Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors
Singh Rahul, Salunke Deepak B.
European Journal of Medicinal Chemistry. 2021 211 p.113071
Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
Carvalho Catarina,
Siegel David,
Inman Martyn,
Xiong Rui,
Ross David, Moody Christopher J.
Organic & Biomolecular Chemistry. 2014 12(17). p.2663
